These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. New perspectives on developing acute stroke therapy. Fisher M; Ratan R Ann Neurol; 2003 Jan; 53(1):10-20. PubMed ID: 12509843 [TBL] [Abstract][Full Text] [Related]
4. [Past, present and future of neuroprotection]. Mracek J Cas Lek Cesk; 2010; 149(12):586-90. PubMed ID: 21387585 [TBL] [Abstract][Full Text] [Related]
5. Current therapies in ischemic stroke. Part A. Recent developments in acute stroke treatment and in stroke prevention. Broussalis E; Killer M; McCoy M; Harrer A; Trinka E; Kraus J Drug Discov Today; 2012 Apr; 17(7-8):296-309. PubMed ID: 22134007 [TBL] [Abstract][Full Text] [Related]
6. The ischemic penumbra: a new opportunity for neuroprotection. Fisher M Cerebrovasc Dis; 2006; 21 Suppl 2():64-70. PubMed ID: 16651816 [TBL] [Abstract][Full Text] [Related]
7. Deterioration in acute ischemic stroke as the target for neuroprotection. Serena J; Rodríguez-Yáñez M; Castellanos M Cerebrovasc Dis; 2006; 21 Suppl 2():80-8. PubMed ID: 16651818 [TBL] [Abstract][Full Text] [Related]
9. The neuroprotective role of erythropoietin in the management of acute ischaemic stroke: from bench to bedside. Ntaios G; Savopoulos C; Chatzinikolaou A; Hatzitolios AI Acta Neurol Scand; 2008 Dec; 118(6):362-6. PubMed ID: 18513348 [TBL] [Abstract][Full Text] [Related]
10. Treatment of acute ischemic stroke: role of ischemic tolerance in intravenous and endovascular therapies. Cornelius JF; Sandu N; Perez-Pinzon MA; Schaller B Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):331-2. PubMed ID: 19379055 [No Abstract] [Full Text] [Related]
11. Ischemic stroke intervention requires mixed cellular protection of the penumbra. Barone FC Curr Opin Investig Drugs; 2009 Mar; 10(3):220-3. PubMed ID: 19333878 [TBL] [Abstract][Full Text] [Related]
12. Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics. Candelario-Jalil E Curr Opin Investig Drugs; 2009 Jul; 10(7):644-54. PubMed ID: 19579170 [TBL] [Abstract][Full Text] [Related]
14. Is it time to definitely abandon neuroprotection in acute ischemic stroke? Sacchetti ML Stroke; 2008 Jun; 39(6):1659-60. PubMed ID: 18369169 [No Abstract] [Full Text] [Related]
15. Current therapies in ischemic stroke. Part B. Future candidates in stroke therapy and experimental studies. Broussalis E; Trinka E; Killer M; Harrer A; McCoy M; Kraus J Drug Discov Today; 2012 Jul; 17(13-14):671-84. PubMed ID: 22405898 [TBL] [Abstract][Full Text] [Related]
16. Opioids modulate post-ischemic progression in a rat model of stroke. Kao TK; Ou YC; Liao SL; Chen WY; Wang CC; Chen SY; Chiang AN; Chen CJ Neurochem Int; 2008 May; 52(6):1256-65. PubMed ID: 18294735 [TBL] [Abstract][Full Text] [Related]
17. [Neuroprotection in acute ischemic stroke. Practicability of guidelines for treatment]. Fridman EA; Ottaviano F; Fiol M; Javelier A; Perea JE; Ameriso SF Rev Neurol; 2001 May 1-15; 32(9):818-21. PubMed ID: 11424030 [TBL] [Abstract][Full Text] [Related]
19. Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability. Cui L; Zhang X; Yang R; Wang L; Liu L; Li M; Du W Brain Res; 2010 Apr; 1325():164-73. PubMed ID: 20167207 [TBL] [Abstract][Full Text] [Related]
20. Is progesterone a candidate neuroprotective factor for treatment following ischemic stroke? Gibson CL; Coomber B; Rathbone J Neuroscientist; 2009 Aug; 15(4):324-32. PubMed ID: 19359672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]